Linden Thomas Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Linden Thomas Advisory Services’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.1M	Buy	49,660 +2,346	+5%	+$208K	0.33%	72
2026 Q2	$4.54M	Buy	47,314 +1,368	+3%	+$140K	0.37%	62
2026 Q1	$5.02M	Buy	45,946 +10,901	+31%	+$1.04M	0.48%	43
2025 Q4	$2.84M	Buy	35,045 +54	+0.2%	+$4.65K	0.29%	95
2025 Q3	$3.06M	Buy	34,991 +438	+1%	+$39.1K	0.31%	82
2025 Q2	$2.87M	Sell	34,553 -1,038	-3%	-$86.7K	0.32%	86
2025 Q1	$2.99M	Buy	35,591 +1,109	+3%	+$103K	0.39%	62
2024 Q4	$3.18M	Buy	34,482 +1,834	+6%	+$176K	0.4%	53
2024 Q3	$3.03M	Buy	32,648 +1,088	+3%	+$94.3K	0.41%	50
2024 Q2	$2.6M	Buy	31,560 +1,034	+3%	+$76K	0.4%	56
2024 Q1	$2.03M	Buy	30,526 +530	+2%	+$32.7K	0.33%	89
2023 Q4	$1.7M	Buy	29,996 +839	+3%	+$44K	0.32%	108
2023 Q3	$1.59M	Buy	29,157 +568	+2%	+$33.7K	0.35%	89
2023 Q2	$1.92M	Buy	+28,589	New	+$1.74M	0.43%	55

Other funds holding LMAT

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Chatham Capital Group Savannah, Georgia $777M AUM 22.3% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Linden Thomas Advisory Services's LMAT Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its LeMaitre Vascular (LMAT) stake by 5% in Q3 2026, buying an estimated $208K and bringing the position to 49,660 shares worth $4.1M. The position accounts for 0.33% of the portfolio, ranked #72.

Linden Thomas Advisory Services first reported a position in LMAT in Q2 2023 and has held it in 14 quarters since. The position peaked at $5.02M in Q1 2026. 49 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

Linden Thomas Advisory Services held 49,660 shares of LeMaitre Vascular worth $4.1M as of Q3 2026.
Linden Thomas Advisory Services bought 2,346 LeMaitre Vascular shares in Q3 2026, an estimated $208K.
LeMaitre Vascular made up 0.33% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #72 holding.
Linden Thomas Advisory Services first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 14 quarters since.
Linden Thomas Advisory Services's LeMaitre Vascular position peaked at $5.02M in Q1 2026.
49 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.